8-K Announcements
6Material company update
Apr 14, 2026·SEC
Material company update
Mar 31, 2026·SEC
Material company update
Feb 20, 2026·SEC
Amrize Ltd(AMRZ)Earnings, Financials & Key Ratios
AMRZ•NYSE
$53.37
$30.26B mkt cap·24.9× P/E·Price updated May 6, 2026
AboutAmrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.Show more
- Revenue$11.81B+0.9%
- EBITDA$2.82B-8.0%
- Net Income$1.19B-16.5%
- EPS (Diluted)2.14-7.0%
- Gross Margin25.68%-2.1%
- EBITDA Margin23.87%-8.9%
- Operating Margin16.13%-13.3%
- Net Margin10.03%-17.3%
- ROE10.23%-31.1%
- ROIC9.19%-11.4%
- Debt/Equity0.45-23.7%
AMRZ Key Insights
Amrize Ltd (AMRZ) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy 5Y average net margin of 10.2%
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AMRZ Price & Volume
Amrize Ltd (AMRZ) stock price & volume — 10-year historical chart
Loading chart...
AMRZ Growth Metrics
Amrize Ltd (AMRZ) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years3.28%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years2.26%
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years2.28%
TTM-
Return on Capital
10 Years9.55%
5 Years9.55%
3 Years9.65%
Last Year8.91%
AMRZ Recent Earnings
Amrize Ltd (AMRZ) EPS & revenue vs analyst estimates — last 3 quarters
●Beat EPS 1/3 qtrs (33%)●Beat Revenue 1/3 qtrs (33%)
Q1 2026Latest
Feb 17, 2026EPS
$0.54
Est $0.65
-16.4%
Revenue
$2.8B
Est $2.9B
-2.8%
Q4 2025
Oct 28, 2025EPS
$1.06
Est $1.02
+3.9%
Revenue
$3.7B
Est $3.5B
+5.4%
Q3 2025
Aug 6, 2025EPS
$0.78
Est $1.03
-24.3%
Revenue
$3.2B
Est $3.4B
-5.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 17, 2026 | $0.54vs $0.65-16.4% | $2.8Bvs $2.9B-2.8% |
| Q4 2025 | Oct 28, 2025 | $1.06vs $1.02+3.9% | $3.7Bvs $3.5B+5.4% |
| Q3 2025 | Aug 6, 2025 | $0.78vs $1.03-24.3% | $3.2Bvs $3.4B-5.0% |
Based on last 3 quarters of dataView full earnings history →
AMRZ Peer Comparison
Amrize Ltd (AMRZ) competitors in Cement and concrete producers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 VMC | 37.82B | 291.51 | 35.90 | 6.94% | 13.88% | 13.07% | 3% | 0.63 |
 MLM | 36.56B | 606.10 | 32.24 | 0.12% | 38.67% | 25.07% | 2.68% | 0.53 |
 EXP | 6.75B | 209.73 | 15.23 | 0.05% | 19.41% | 29.07% | 5.23% | 0.88 |
 CRH | 75.17B | 112.50 | 20.42 | 9.01% | 9.21% | 20.58% | 3.35% | 0.77 |
 FYBR | 9.64B | 38.49 | -29.61 | 3.23% | -6.24% | -8.11% | 2.44 | |
 BCPC | 5.16B | 161.13 | 33.92 | 8.75% | 14.95% | 12.38% | 3.35% | 0.15 |
 USLM | 3.05B | 106.45 | 22.79 | 17.31% | 35.4% | 21.28% | 3.35% | 0.01 |
 CAT | 420.89B | 904.59 | 48.04 | 4.29% | 13.31% | 47.51% | 2.44% | 2.03 |
Compare AMRZ vs Peers
Amrize Ltd (AMRZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMRZ Income Statement
Amrize Ltd (AMRZ) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Sales/Revenue | 10.73B | 11.68B | 11.7B | 11.81B |
| Revenue Growth % | - | 8.87% | 0.23% | 0.95% |
| Cost of Goods Sold | 8.25B | 8.91B | 8.63B | 8.78B |
| COGS % of Revenue | 76.95% | 76.29% | 73.77% | 74.32% |
| Gross Profit | 2.47B▲ 0% | 2.77B▲ 12.0% | 3.07B▲ 10.9% | 3.03B▼ 1.2% |
| Gross Margin % | 23.05% | 23.71% | 26.23% | 25.68% |
| Gross Profit Growth % | - | 12.01% | 10.87% | -1.17% |
| Operating Expenses | 773M | 881M | 893M | 1.13B |
| OpEx % of Revenue | 7.21% | 7.54% | 7.63% | 9.55% |
| Selling, General & Admin | 752M | 898M | 962M | 1.13B |
| SG&A % of Revenue | 7.01% | 7.69% | 8.22% | 9.55% |
| Research & Development | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - |
| Other Operating Expenses | 21M | -17M | -69M | 0 |
| Operating Income | 1.7B▲ 0% | 1.89B▲ 11.1% | 2.18B▲ 15.3% | 1.91B▼ 12.4% |
| Operating Margin % | 15.84% | 16.17% | 18.6% | 16.13% |
| Operating Income Growth % | - | 11.12% | 15.31% | -12.45% |
| EBITDA | 2.49B | 2.74B | 3.07B | 2.82B |
| EBITDA Margin % | 23.19% | 23.46% | 26.2% | 23.87% |
| EBITDA Growth % | - | 10.13% | 11.94% | -8.02% |
| D&A (Non-Cash Add-back) | 788M | 851M | 889M | 914M |
| EBIT | 1.71B | 1.85B | 2.12B | 1.91B |
| Net Interest Income | -248M | -549M | -302M | -413M |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 248M | 549M | 302M | 0 |
| Other Income/Expense | -226M | -572M | -344M | -398M |
| Pretax Income | 1.47B▲ 0% | 1.32B▼ 10.7% | 1.83B▲ 39.3% | 1.51B▼ 17.7% |
| Pretax Margin % | 13.73% | 11.27% | 15.66% | 12.76% |
| Income Tax | 366M | 361M | 415M | 326M |
| Effective Tax Rate % | 24.85% | 27.43% | 22.64% | 21.62% |
| Net Income | 1.11B▲ 0% | 956M▼ 13.7% | 1.42B▲ 48.4% | 1.19B▼ 16.5% |
| Net Margin % | 10.33% | 8.19% | 12.12% | 10.03% |
| Net Income Growth % | - | -13.72% | 48.43% | -16.49% |
| Net Income (Continuing) | 1.11B | 955M | 1.42B | 1.18B |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 1M | 0 | -1M | 0 |
| EPS (Diluted) | 2.00▲ 0% | 1.73▼ 13.5% | 2.30▲ 32.9% | 2.14▼ 7.0% |
| EPS Growth % | - | -13.5% | 32.95% | -6.96% |
| EPS (Basic) | 2.00 | 1.73 | 2.30 | 2.14 |
| Diluted Shares Outstanding | 552.7M | 552.7M | 553.3M | 553.6M |
| Basic Shares Outstanding | 552.7M | 552.7M | 553.3M | 553.74M |
| Dividend Payout Ratio | - | - | - | - |
AMRZ Balance Sheet
Amrize Ltd (AMRZ) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Total Current Assets | 3.16B | 3.94B | 4.78B | 4.68B |
| Cash & Short-Term Investments | 351M | 1.11B | 1.82B | 1.92B |
| Cash Only | 351M | 1.11B | 1.82B | 1.92B |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.41B | 1.4B | 1.63B | 1.12B |
| Days Sales Outstanding | 47.98 | 43.7 | 50.86 | 34.6 |
| Inventory | 1.23B | 1.31B | 1.45B | 1.55B |
| Days Inventory Outstanding | 54.3 | 53.55 | 61.38 | 64.47 |
| Other Current Assets | 51M | 40M | -219M | 0 |
| Total Non-Current Assets | 17.51B | 19.11B | 19.02B | 19.57B |
| Property, Plant & Equipment | 7.75B | 8.07B | 8.08B | 8.54B |
| Fixed Asset Turnover | 1.38x | 1.45x | 1.45x | 1.38x |
| Goodwill | 8.12B | 8.97B | 8.92B | 9.02B |
| Intangible Assets | 1.44B | 1.88B | 1.83B | 1.73B |
| Long-Term Investments | 0 | 63M | 56M | 0 |
| Other Non-Current Assets | 202M | 121M | 138M | 277M |
| Total Assets | 20.67B▲ 0% | 23.05B▲ 11.5% | 23.8B▲ 3.3% | 24.25B▲ 1.9% |
| Asset Turnover | 0.52x | 0.51x | 0.49x | 0.49x |
| Asset Growth % | - | 11.5% | 3.29% | 1.87% |
| Total Current Liabilities | 2.25B | 2.44B | 2.43B | 2.86B |
| Accounts Payable | 1.14B | 1.25B | 1.29B | 1.54B |
| Days Payables Outstanding | 50.59 | 51.14 | 54.66 | 63.93 |
| Short-Term Debt | 348M | 131M | 5M | 333M |
| Deferred Revenue (Current) | 43M | 48M | 67M | 0 |
| Other Current Liabilities | 464M | 532M | 466M | 850M |
| Current Ratio | 1.40x | 1.61x | 1.97x | 1.64x |
| Quick Ratio | 0.86x | 1.08x | 1.37x | 1.10x |
| Cash Conversion Cycle | 51.7 | 46.12 | 57.59 | 35.14 |
| Total Non-Current Liabilities | 10.21B | 11.4B | 7.78B | 8.14B |
| Long-Term Debt | 7.62B | 8.64B | 4.94B | 4.94B |
| Capital Lease Obligations | 516M | 564M | 698M | 500M |
| Deferred Tax Liabilities | 944M | 998M | 937M | 0 |
| Other Non-Current Liabilities | 873M | 930M | 868M | 2.7B |
| Total Liabilities | 12.46B | 13.84B | 13.89B | 10.99B |
| Total Debt | 8.66B | 9.52B | 5.79B | 5.91B |
| Net Debt | 8.31B | 8.42B | 3.96B | 3.98B |
| Debt / Equity | 1.05x | 1.03x | 0.58x | 0.45x |
| Debt / EBITDA | 3.48x | 3.48x | 1.89x | 2.09x |
| Net Debt / EBITDA | 3.34x | 3.07x | 1.29x | 1.41x |
| Interest Coverage | 6.85x | 3.44x | 7.21x | - |
| Total Equity | 8.21B▲ 0% | 9.2B▲ 12.1% | 9.91B▲ 7.7% | 13.25B▲ 33.7% |
| Equity Growth % | - | 12.1% | 7.73% | 33.69% |
| Book Value per Share | 14.85 | 16.65 | 17.92 | 23.94 |
| Total Shareholders' Equity | 8.21B | 9.2B | 9.91B | 13.25B |
| Common Stock | 0 | 0 | 6M | 13.25B |
| Retained Earnings | 0 | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | -372M | -317M | 9.91B | 0 |
| Minority Interest | 1M | 0 | -1M | 0 |
AMRZ Cash Flow Statement
Amrize Ltd (AMRZ) cash flow — operating, investing & free cash flow history
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Cash from Operations | 1.99B | 2.04B | 2.28B | 2.21B |
| Operating CF Margin % | 18.53% | 17.44% | 19.5% | 18.69% |
| Operating CF Growth % | - | 2.41% | 12.08% | -3.24% |
| Net Income | 1.11B | 955M | 1.27B | 1.19B |
| Depreciation & Amortization | 788M | 851M | 889M | 914M |
| Stock-Based Compensation | 4M | 5M | 6M | 0 |
| Deferred Taxes | 66M | 11M | -35M | 0 |
| Other Non-Cash Items | 9M | 97M | 111M | 425M |
| Working Capital Changes | 14M | 117M | 38M | -316M |
| Change in Receivables | 35M | -82M | 189M | -43M |
| Change in Inventory | -296M | -7M | -146M | -61M |
| Change in Payables | 195M | 60M | 28M | 0 |
| Cash from Investing | -2.52B | -2.02B | -1.21B | -361M |
| Capital Expenditures | -488M | -630M | -642M | -788M |
| CapEx % of Revenue | 4.55% | 5.4% | 5.49% | 6.67% |
| Acquisitions | -2.03B | -1.61B | -249M | -86M |
| Investments | - | - | - | - |
| Other Investing | 0 | 212M | -317M | 513M |
| Cash from Financing | 497M | 734M | -537M | -1.55B |
| Debt Issued (Net) | 725M | 747M | -225M | -2.23B |
| Equity Issued (Net) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 |
| Other Financing | -228M | -13M | -312M | 675M |
| Net Change in Cash | -48M▲ 0% | 756M▲ 1675.0% | 478M▼ 36.8% | 337M▼ 29.5% |
| Free Cash Flow | 1.5B▲ 0% | 1.41B▼ 6.3% | 1.64B▲ 16.6% | 1.42B▼ 13.4% |
| FCF Margin % | 13.98% | 12.04% | 14.01% | 12.02% |
| FCF Growth % | - | -6.27% | 16.64% | -13.41% |
| FCF per Share | 2.71 | 2.54 | 2.96 | 2.57 |
| FCF Conversion (FCF/Net Income) | 1.79x | 2.13x | 1.61x | 1.86x |
| Interest Paid | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 |
AMRZ Key Ratios
Amrize Ltd (AMRZ) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Return on Equity (ROE) | 13.5% | 10.98% | 14.85% | 10.23% |
| Return on Invested Capital (ROIC) | 7.71% | 8.3% | 10.37% | 9.19% |
| Gross Margin | 23.05% | 23.71% | 26.23% | 25.68% |
| Net Margin | 10.33% | 8.19% | 12.12% | 10.03% |
| Debt / Equity | 1.05x | 1.03x | 0.58x | 0.45x |
| Interest Coverage | 6.85x | 3.44x | 7.21x | - |
| FCF Conversion | 1.79x | 2.13x | 1.61x | 1.86x |
| Revenue Growth | - | 8.87% | 0.23% | 0.95% |
AMRZ SEC Filings & Documents
Amrize Ltd (AMRZ) SEC filings — annual & quarterly reports (10-K, 10-Q)
AMRZ Frequently Asked Questions
Amrize Ltd (AMRZ) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Amrize Ltd (AMRZ) reported $11.81B in revenue for fiscal year 2025. This represents a 10% increase from $10.73B in 2022.
Amrize Ltd (AMRZ) grew revenue by 0.9% over the past year. Growth has been modest.
Yes, Amrize Ltd (AMRZ) is profitable, generating $1.22B in net income for fiscal year 2025 (10.0% net margin).
Dividend & Returns
Amrize Ltd (AMRZ) has a return on equity (ROE) of 10.2%. This is reasonable for most industries.
Amrize Ltd (AMRZ) generated $1.42B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More AMRZ
Amrize Ltd (AMRZ) financial analysis — history, returns, DCA and operating performance tools
Full AMRZ Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates